HBK Investments »

Amicus Therapeutics shares owned by HBK Investments

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by HBK Investments from 13F filings

Historical chart of HBK Investments investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by HBK Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by HBK Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $217M 15M 14.24
2015-09-30 $1.3M 91k 13.99

More positions owned by HBK Investments

NVIDIA Corporation Put Option (NVDA)
Cyberark Software SHS (CYBR)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
EXACT Sciences Corporation (EXAS)
Hologic (HOLX)
Norfolk Southern (NSC)
Ceridian Hcm Hldg
Confluent Class A Com (CFLT)
Chart Industries (GTLS)
Electronic Arts (EA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Comerica Incorporated
Avidity Biosciences Ord (RNA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Frontier Communications Pare

View all positions for HBK Investments

Top funds holding Amicus Therapeutics

BlackRock
Vanguard Group
HBK Investments
State Street Corporation
Pentwater Capital Management
Bellevue Group
William Blair Investment Management
Geode Capital Management
Perceptive Advisors
Goldman Sachs Group
UBS Group
Soleus Capital Management
Palo Alto Investors
Balyasny Asset Management
Citadel Advisors

View all funds holding Amicus Therapeutics